Proteomics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Enzyme Research
Studies from University of Manchester in the area of enzyme research described
June 8th, 2009
According to a study from Manchester, the United Kingdom, "The plaque-control potential of commercially available amylase, lipase and protease was evaluated by observing their effects on coaggregation and on bacterial viability within various plaque microcosms. A quantitative coaggregation assay indicated that protease significantly inhibited the extent of coaggregation of Actinomyces naeslundii and Streptococcus oralis (P <0.05) and of Porphyromonas gingivalis and S. oralis." "Amylase significantly (P <0.05) increased the coaggregation of A. naeslundii versus Fusobacterium, nucleatum and A. naeslundii versus P. gingivalis. Concomitant challenge of constant-depth...
Source: Proteomics Weekly (2009-06-08)
|
